In AD patients, low levels of GCSF and IL-15 have been reported (Renzos et al., 2007; Laske et al., 2009) and faster disease progression was found in AD patients with low plasma cytokine levels compared to those with high levels (Taipa et al., 2019). The gene discussed is CSF3; the disease is Alzheimer disease.